These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11154145

  • 1. Capillary microscopic and rheological dimensions for the diagnosis of von Willebrand disease in comparison to other haemorrhagic diatheses.
    Koscielny JK, Latza R, Mürsdorf S, Mrowietz C, Kiesewetter H, Wenzel E, Jung F.
    Thromb Haemost; 2000 Dec; 84(6):981-8. PubMed ID: 11154145
    [Abstract] [Full Text] [Related]

  • 2. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
    Schlammadinger A, Kerényi A, Muszbek L, Boda Z.
    Orv Hetil; 2000 Oct 08; 141(41):2245-50. PubMed ID: 11184249
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A, Kerenyi A, Muszbek L, Boda Z.
    Thromb Haemost; 2000 Jul 08; 84(1):88-92. PubMed ID: 10928476
    [Abstract] [Full Text] [Related]

  • 4. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S, Mezzasoma AM, Leone M, Gresele P.
    Haematologica; 2007 Dec 08; 92(12):1647-54. PubMed ID: 18055988
    [Abstract] [Full Text] [Related]

  • 5. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I.
    Blood Coagul Fibrinolysis; 2006 Jan 08; 17(1):39-45. PubMed ID: 16607078
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB.
    Semin Thromb Hemost; 2006 Sep 08; 32(6):555-65. PubMed ID: 16977566
    [Abstract] [Full Text] [Related]

  • 7. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep 08; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study.
    Federici AB.
    Haemophilia; 2007 Dec 08; 13 Suppl 5():15-24. PubMed ID: 18078393
    [Abstract] [Full Text] [Related]

  • 10. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr 08; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U, Drewke E, Mainusch K, Schneppenheim R.
    Semin Thromb Hemost; 2002 Apr 08; 28(2):173-90. PubMed ID: 11992241
    [Abstract] [Full Text] [Related]

  • 13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Apr 08; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.
    Semin Thromb Hemost; 2002 Apr 08; 28(2):161-6. PubMed ID: 11992239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease.
    Woods AI, Blanco AN, Chuit R, Meschengieser SS, Kempfer AC, Farías CE, Lazzari MA.
    Thromb Haemost; 2008 Nov 08; 100(5):797-802. PubMed ID: 18989523
    [Abstract] [Full Text] [Related]

  • 19. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 08; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 20. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Jul 08; 12(3):277-95. PubMed ID: 16959681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.